Literature DB >> 9665199

Establishment and characterization of a megakaryoblast cell line with amplification of MLL.

R J Allen1, S D Smith, R L Moldwin, M M Lu, L Giordano, C Vignon, Y Suto, A Harden, R Tomek, T Veldman, T Ried, R A Larson, M M Le Beau, J D Rowley, N Zeleznik-Le.   

Abstract

A new cell line with megakaryoblastic features, designated UoC-M1, was established from the malignant cells of a 68-year-old patient with acute myeloid leukemia. The patient's leukemic cells reacted with alpha-naphthyl acetate esterase and acid phosphatase and expressed CD7, CD24, CD34, CD38, CD45, HLA-DR and CD61. Cytogenetic analysis of the patient's malignant cells (and of the UoC-M1 cells) showed a human, male hypodiploid karyotype with many chromosome rearrangements and marker chromosomes. Spectral karyotyping (SKY) analysis complemented the G-banded karyotyping and clarified several chromosomal translocations and identified the marker chromosomes. Fluorescence in situ hybridization (FISH) and SKY analysis demonstrated that one marker chromosome contained three segments of chromosome 9 interspersed with three segments of chromosome 11, as well as a portion of chromosome 19. FISH analysis with a probe for MLL revealed that the UoC-M1 cells contained four copies of the MLL gene. Southern blot analysis determined that the MLL gene had a germline profile while Northern and Western analyses showed that the MLL mRNAs and protein were of the appropriate sizes. This is the first report of amplification of the MLL gene which may be an additional mechanism of leukemogenesis or disease progression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9665199     DOI: 10.1038/sj.leu.2401002

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  7 in total

1.  Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer cell lines by sequential giemsa banding and spectral karyotyping.

Authors:  B Beheshti; J Karaskova; P C Park; J A Squire; B G Beatty
Journal:  Mol Diagn       Date:  2000-03

2.  Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia.

Authors:  Zhijian Qian; Anthony A Fernald; Lucy A Godley; Richard A Larson; Michelle M Le Beau
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

3.  Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia.

Authors:  C Lavau; C Du; M Thirman; N Zeleznik-Le
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

4.  The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B (p27kip1) expression.

Authors:  Zhen-Biao Xia; Relja Popovic; Jing Chen; Catherine Theisler; Tara Stuart; Donna A Santillan; Frank Erfurth; Manuel O Diaz; Nancy J Zeleznik-Le
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-16       Impact factor: 11.205

5.  Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia.

Authors:  Yanming Zhang; Pamela Strissel; Reiner Strick; Jianjun Chen; Giuseppina Nucifora; Michelle M Le Beau; Richard A Larson; Janet D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

6.  Heat-shock protein expression in leukemia.

Authors:  Lucie Sedlackova; Martin Spacek; Ernst Holler; Zuzana Imryskova; Ilona Hromadnikova
Journal:  Tumour Biol       Date:  2010-08-07

7.  Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models.

Authors:  Clarisse Thiollier; Cécile K Lopez; Bastien Gerby; Cathy Ignacimouttou; Sandrine Poglio; Yannis Duffourd; Justine Guégan; Paola Rivera-Munoz; Olivier Bluteau; Vinciane Mabialah; M'boyba Diop; Qiang Wen; Arnaud Petit; Anne-Laure Bauchet; Dirk Reinhardt; Beat Bornhauser; Daniel Gautheret; Yann Lecluse; Judith Landman-Parker; Isabelle Radford; William Vainchenker; Nicole Dastugue; Stéphane de Botton; Philippe Dessen; Jean-Pierre Bourquin; John D Crispino; Paola Ballerini; Olivier A Bernard; Françoise Pflumio; Thomas Mercher
Journal:  J Exp Med       Date:  2012-10-08       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.